Olanzapine: all 266 studies that test it
Page 2 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular CancerStatus unknownNCT05244577Phase 3
- Olanzapine Anorexia CachexiaCompletedNCT05243251Phase 3
- The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCsStatus unknownNCT05202275Phase 2
- Olanzapine in OUD PatientsWithdrawnNCT05179772Phase 2
- Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.CompletedNCT05123976Phase 1
- Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I DisorderCompletedNCT04987658Phase 1
- Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer PatientsActive, not recruitingNCT04939090Phase 3
- Comparing Haloperidol and Olanzapine in Treating Terminal DeliriumStatus unknownNCT04750395Phase 2
- Olanzapine for the Prevention of Postoperative Nausea and VomitingCompletedNCT04718727Phase 1/2
- Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast CancerCompletedNCT04669132Phase 2
- Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic SyndromeSuspendedNCT04518319Phase 2
- Olanzapine for Chemotherapy-induced Nausea and Vomiting ProphylaxisCompletedNCT04232423Phase 3
- Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapyCompletedNCT04075955Phase 3
- Rolapitant Plus Olanzapine in Multiday Cisplatin ChemotherapyWithdrawnNCT03960151Phase 2
- Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic ChemotherapyStatus unknownNCT03876938Phase 3
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaActive, not recruitingNCT03781115Phase 1
- Intranasal Insulin and Olanzapine Study in Healthy VolunteersCompletedNCT03741478Phase 1
- Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical AntipsychoticsCompletedNCT03730857Phase 1
- Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer CareStatus unknownNCT03679182Phase 2
- Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic PatientsCompletedNCT03631004Phase 2/3
- Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric CancerStatus unknownNCT03575637Phase 2
- Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung CancerStatus unknownNCT03571126Phase 4
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
- Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) ProphylaxisStatus unknownNCT03478605Phase 2
- Oral Olanzapine Versus Haloperidol or DiazepamTerminatedNCT03246620Phase 4
- "Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)"CompletedNCT03219710Phase 3
- RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyCompletedNCT03118986Phase 2
- Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Chinese Breast Cancer PatientsCompletedNCT03079219Phase 3
- Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CINStatus unknownNCT02970643Not applicable
- An Insulin Sensitivity Study in Healthy SubjectsCompletedNCT02922426Phase 1
- Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD StudyCompletedNCT02861859Phase 3
- A Phase 1 Safety Study in Adults With SchizophreniaCompletedNCT02804568Phase 1
- Molecular Mechanisms of Antipsychotic-induced Insulin ResistanceCompletedNCT02708394Early Phase 1
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic TreatmentStatus unknownNCT02650102Phase 1/2
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaCompletedNCT02593734Phase 4
- Effect of Short Term Atypical Antipsychotic Administration Compared to Placebo on Hepatic Insulin ExtractionCompletedNCT02447835Phase 1
- 5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset SchizophreniaCompletedNCT02435654Phase 4
- A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic ChemotherapyStatus unknownNCT02400866Phase 2
- IM Olanzapine Versus Haloperidol or MidazolamTerminatedNCT02380118Phase 4
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
- Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus PaclitaxelStatus unknownNCT02290470Phase 2
- Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)CompletedNCT02287259Phase 4
- Efficacy and Safety of A-prexa Compared to Zyprexa in Patients With SchizophreniaCompletedNCT02137993Phase 4
- Antipsychotic to Treat Psychosis SyndromeStatus unknownNCT02137616Not applicable
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction StudyCompletedNCT02051387Phase 1
- Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic EpisodeCompletedNCT01977300Phase 3
- Comparative Efficacy and Acceptability of Antimanic Drugs in Acute ManiaStatus unknownNCT01893229Phase 4
- Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar DisorderCompletedNCT01864551Phase 4
- Comparison of Antipsychotic Combination Treatment of Olanzapine and Amisulpride to MonotherapyCompletedNCT01609153Phase 4
- A Study to Compare Capillary and Venous Whole Blood and Plasma Concentrations of Five AntipsychoticsCompletedNCT01607762Phase 1
- Early Recognition and Optimal Treatment of Delirium in Patients With Advanced CancerCompletedNCT01539733Not applicable
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed ConditionCompletedNCT01503450Phase 1
- Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting ConditionCompletedNCT01503437Phase 1
- Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed StudyCompletedNCT01503424Phase 1
- Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01503398Phase 1
- Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy EvaluationCompletedNCT01485692Not applicable
- Bergen Psychosis Project 2 - The Best Intro StudyCompletedNCT01446328Phase 4
- Acute Impact of Intramuscular (IM) Aripiprazole and Olanzapine on Insulin Resistance in High Risk PrediabeticsCompletedNCT01411930Phase 4
- A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01389908Not applicable
- Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ DepressionCompletedNCT01303601Phase 4
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRICompletedNCT01234454Not applicable
- Antipsychotics and Gene Expression in Soft TissuesCompletedNCT01185743Phase 4
- Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and AdolescentsTerminatedNCT01184443Phase 3
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaCompletedNCT01164059Phase 4
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose MetabolismCompletedNCT01160991Not applicable
- Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia PatientsCompletedNCT01149577Phase 4
- Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough EmesisTerminatedNCT01148264Phase 2
- Clozapine and Olanzapine Treatment of AggressionCompletedNCT01123408Not applicable
- Standard Comprehensive Intervention to Treat First-episode SchizophreniaStatus unknownNCT01057849Not applicable
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of SchizophreniaCompletedNCT01052389Phase 4
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedNCT00977301Phase 1
- Tardive Dyskinesia and Cognitive FunctionCompletedNCT00926965Phase 4
- Polypharmacy in Clozapine-resistant SchizophreniaCompletedNCT00918021Phase 4
- Metabolic Effects of Antipsychotic Substitution in ChildrenWithdrawnNCT00910780Phase 2/3
- Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)TerminatedNCT00885690Not applicable
- Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00876772Phase 2/3
- Haloperidol vs Olanzapine for the Management of ICU DeliriumTerminatedNCT00833300Not applicable
- A Study in the Treatment of Acute ManiaTerminatedNCT00767715Phase 4
- Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer PainWithdrawnNCT00737191Not applicable
- Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic SubjectsTerminatedNCT00734435Phase 2
- Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
- Prophylactic Olanzapine Versus Placebo for Prevention of Postoperative Delirium After Joint Replacement SurgeryCompletedNCT00699946Not applicable
- Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical TrialCompletedNCT00678457Phase 2
- Cardio Risk of Acute Schizophrenia Olanzapine DukeWithdrawnNCT00672464Phase 4
- Fasting Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00648921Phase 1
- Fasting Study of Olanzapine Tablets 20 mg and Zyprexa® Tablets 20 mgTerminatedNCT00647972Phase 1
- Food Study of Olanzapine Tablets 5 mg and Zyprexa® Tablets 5 mgCompletedNCT00647777Phase 1
- Effects of Modafinil on Olanzapine Weight GainCompletedNCT00636896Not applicable
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and TiaprideCompletedNCT00632645Phase 3
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive DyskinesiaCompletedNCT00621998Phase 4
- Olanzapine in the Treatment of Anorexia NervosaCompletedNCT00592930Phase 4
- Optimal Duration of Olanzapine Add-on Therapy in Major DepressionWithdrawnNCT00568672Phase 3
- Metabolic Profile and Anthropometric Changes in SchizophreniaCompletedNCT00534183Not applicable
- An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed PatientsCompletedNCT00520507Phase 4
- Subcutaneous Olanzapine for Hyperactive or Mixed DeliriumCompletedNCT00512291Not applicable
- Olanzapine in Patients With Advanced Cancer and Weight LossCompletedNCT00489593Phase 1
- Weight Gain Management in Patients With SchizophreniaCompletedNCT00486005Phase 4